Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Cancer Treatment Reports
|
October 1, 1986
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion
J F Belliveau, M R Posner, L Ferrari, et al.
Oral Oncology
|
November 24, 2020
Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance
S S Mashiana, P Navale, B Khandakar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2012
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy
D J Sher, V Thotakura, T A Balboni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck
M R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Docetaxel: an active drug for squamous cell carcinoma of the head and neck
A I Dreyfuss, J R Clark, C M Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
T J Ervin, J R Clark, R R Weichselbaum, et al.
The Journal of Infectious Diseases
|
January 1, 1993
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial
M J Browne, K H Mayer, S B Chafee, et al.
American Journal of Clinical Oncology
|
April 11, 2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)
A D Colevas, C M Norris, R B Tishler, et al.
AIDS Research and Human Retroviruses
|
May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins
A Li, T W Baba, J Sodroski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
A D Colevas, C M Norris, R B Tishler, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Cancer Treatment Reports
|
October 1, 1986
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion
J F Belliveau, M R Posner, L Ferrari, et al.
Oral Oncology
|
November 24, 2020
Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance
S S Mashiana, P Navale, B Khandakar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2012
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy
D J Sher, V Thotakura, T A Balboni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck
M R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Docetaxel: an active drug for squamous cell carcinoma of the head and neck
A I Dreyfuss, J R Clark, C M Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
T J Ervin, J R Clark, R R Weichselbaum, et al.
The Journal of Infectious Diseases
|
January 1, 1993
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial
M J Browne, K H Mayer, S B Chafee, et al.
American Journal of Clinical Oncology
|
April 11, 2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)
A D Colevas, C M Norris, R B Tishler, et al.
AIDS Research and Human Retroviruses
|
May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins
A Li, T W Baba, J Sodroski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
A D Colevas, C M Norris, R B Tishler, et al.
Page
of 11